Opioids are medications prescribed by
doctors and physicians to treat various levels of pain. These can include acute
pain and chronic non-cancer pain. They are also known as painkillers and used
to block pain signals from the brain. Market Research Future (MRFR) has
stressed the advantages of the intake of opioids as well as the efforts by
manufacturers to address various issues concerning the drugs.
Growth Drivers
The opioids
market is expected to reach USD 6,060.17 million at CAGR of 4.90% during
the forecast period 2022-2030. Pain management of various chronic diseases
remain the primary driver of the market. According to the National Institute of
Drug Abuse, nearly 200 million prescriptions were dispensed by U.S. pharmacies
in 2017. The large number of prescriptions is an indicator for the large scope
of the market.
Favorable reimbursement schemes for
covering the costs of opioids in palliative care can work in favor of the
market. Large number of patients diagnosed with various cancers can drive the
market demand for opioids till 2023. Rise in surgical procedures and road
accidents are other factors which can contribute to market demand due to the
need for pain relievers. All of these factors are predicted to push the market
to exhibit a CAGR of 7.12% during the forecast period.
Establishment of new guidelines to curb the
intake of opioids and reduce the addiction rates are expected to disrupt the
market in a positive manner. For instance, the sale of over-the-counter drugs
containing opioids is restricted, while stringent measures are undertaken
regarding prescriptions given by doctors. New policies by government-supported
insurance companies such as Medicare are limiting the dispensation rate of
opioids to 7 days.
But misuse of viatris opioids and adverse
effects of the drugs which lead to addiction threaten the market growth.
Segments In-Detail:
MRFR has segmented the global opioids
market by product, application, and end-user.
Based on the product, the market is
segmented into immediate release/short-acting opioid and extended
release/long-acting opioid. Extended release comprises hydromorphone,
oxycodone, morphine, oxymorphone, and others. The extended release segment had
accounted for USD 12,750.91 million in 2017. This segment can expand in the
coming years due to rising prevalence of chronic diseases.
By application, it is segmented into
diarrhea suppression, deaddiction, cough suppression, pain
relief, anesthesia, and others. The pain relief segment is expected to be
the dominant application of the opioids market due to rise in pain management
therapies. Moreover, new guidelines for selling prescription drugs coupled with
rise in palliative and end-of-life care can boost segment growth. This in turn
can drive the market demand exponentially.
By end-user, the market caters to academic
research institutes, hospitals & clinics, and pharmacies.
Regional Analysis:
MRFR’s report takes a deep look into major
regions which include the Americas, Europe, Asia Pacific (APAC), and the Middle
East and Africa (MEA).
The Americas is predicted to be dominant in
the global market due to holding the largest market share due to awareness
among patients and the high intake of the drugs for pain alleviation. On the
other hand, Europe is expected to showcase prolific growth due to rise in
palliative care centers and strict regulations regarding opioid usage.
A Look at the Competition:
Prominent companies operating in the opioids
market players include Janssen Global Services, LLC, Egalet Corporation,
Teva Pharmaceutical Industries Ltd, Pfizer Inc., Sanofi SA, Purdue Pharma L.P,
Boehringer Ingelheim GmbH, Allergan Inc., Sun Pharmaceutical Industries Ltd.,
Mallinckrodt, Vertice Pharma LLC, and West-Ward Pharmaceuticals
Corporation.
New in Research
Opioid-induced constipation is on the rise
due to being one of the side-effects during intake of pain relievers. In 2019,
Novartis has agreed to partner with Shinogi & Co Ltd, for bringing to
market Rizmoic in selected areas of the Netherlands, the U.K., and Germany.
According to a study published by the
researchers at the University of Pennsylvania School of Medicine, patients in
the United States and Canada are more likely to procure opioids due to the
large number of chronic diseases. High prevalence of minimally invasive
surgeries and prescription of codeine in post-operative care can bode well for
the global opioids market in the coming years.
About US:
Market Research Future (MRFR), enable customers to
unravel the complexity of various industries through Cooked Research Report
(CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R),
Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Market Analysis
Dental
Biomaterials Market Overview, by Type, by Application, by End User, Forecast
till 2030. The dental biomaterials market is anticipated to reach USD
8720.26 Million by 2030 at 5.9% CAGR during the forecast period 2022-2030,
reveals the new Market Research Future (MRFR) report. Dental biomaterials,
simply put, are natural or fabricated structures that are utilized in dentistry
for orthodontics, prosthodontics, implantology, and others.
Various factors are propelling the dental biomaterials
market growth. Such factors, as per the latest Market Research Future report,
include the growing awareness about the significance of dental implants, rise
in disposable income, rising investments in the dental industry, and growing
dental tourism. Additional factors pushing the growth of the dental
biomaterials market include increasing dental expenditure and increasing
incidence of dental trauma and dental caries.
On the contrary, scarcity of dental professionals, presence
of strict clinical and regulatory processes, reported cases of peri-implant and
peri-implantitis mucositis, and the soaring cost of implants are factors that
may deter the dental biomaterials market growth during the forecast period.
Market Segmentation
The Market Research Future report provides an all-inclusive
segmental analysis of the dental biomaterials market on the basis of end user,
type, and application.
By type, the dental biomaterials market is segmented into
natural biomaterials,
metal-ceramic biomaterials, polymeric biomaterials, ceramic biomaterials, and
metallic biomaterials. The metallic biomaterials segment is again segmented
into chromium alloys, stainless steel, titanium, and others. Of these, metallic
biomaterials will dominate the market during the forecast period. Various
factors propelling the growth of the segment include its extensive applications
in dentistry and rising penetration of dental implants.
By application, the dental biomaterials market is segmented
into orthodontics, prosthodontics, implantology, and others. Of these, the
implantology segment will have the maximum share in the market during the
forecast period. Various factors propelling the growth of the segment include
the rising disposable income, growing dental tourism, bourgeoning demand for
cosmetic dentistry, growing prevalence of dental diseases, high volume needs,
and price of titanium used to manufacture dental implants, and rising penetration
of dental implants worldwide.
By end users, the dental biomaterials market is segmented
into research institutes, dental academics, dental hospitals & clinics,
dental laboratories, and dental product manufacturers. Of these, dental product
manufacturers will lead the market during the forecast period. Various factors
propelling the growth of the segment include the growing awareness of oral
diseases, rising number of dental practices, growing adoption of CAM/CAD
systems in laboratories and dental clinics, and increasing penetration of dental
implants as well as prosthetics.
Regional Analysis
By region, the dental
biomaterials market research report covers the latest trends and growth
opportunities across the Americas, the Asia Pacific, the Middle East and
Africa, and Europe. Of these, the Americas will lead the market during the
forecast period. Factors pushing the growth of the dental biomaterials market
in the region include evolving dental care infrastructure, highest diabetic
population, early adoption of latest dental biomaterials, mounting prevalence
and awareness of dental disorders, high dental expenditure, and presence of
notable players in the region. China, as well as India, are the major
contributors in the region.
The dental biomaterials market in Europe will have the
second-largest share in the market during the forecast period. Factors pushing
the growth of the dental biomaterials market in the region include rising
government funding on oral healthcare, rising number of dental procedures,
presence of various developed economies, increase in dental hospitals &
clinics, growing geriatric population, and increasing use of dental
biomaterials for manufacturing implants as well as other dental products.
The dental biomaterials market in the APAC region will grow
at the fastest pace during the forecast period. Factors pushing the growth of
the dental biomaterials market in the region include growing awareness about
oral health coupled with the rapidly developing dental industries.
The dental biomaterials market in the MEA will have a
minimal share during the forecast period owing to low healthcare expenditure,
lack of awareness, and the presence of poor economies.
Key Players
Notable players profiled in the dental biomaterials market
report include Cam Bioceramics BV, Bego Medical GmbH, Datum Dental Ltd,
Keystone Dental, Inc., GC Corporation, Ivoclar Vivadent AG, Victrex PLC, Mitsui
Chemicals, Inc., Henry Schein, Inc., Medtronic PLC, Kuraray Co., Ltd, Carpenter
Technology Corporation, Royal DSM, 3M Company, Dentsply Sirona, Inc., Danaher
Corporation, Zimmer Biomet Holdings, Inc., Geistlich Pharma AG, and Straumann
Holding AG. Key players have incorporated different strategies for sustaining
the competitive environment, such as research and development for advancements
in dental biomaterials, product approvals and product launches.
About US:
Market Research Future (MRFR), enable customers to unravel the complexity
of various industries through Cooked Research Report (CRR), Half-Cooked
Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research
(CFR), and Market Research & Consulting Services.
Clinical alarm management systems are likely to gain quick
mileage in the foreseeable future. It has been assessed in a report published
by Market Research Future (MRFR) that The clinical
alarm management market size was valued USD 1.02 billion in 2021 and is
expected to reach USD 5.35 billion by 2030 at 31.30% CAGR during the forecast
period 2022-2030. These systems are non-invasive and send a warning to the
doctors and nurses in case of emergencies. Increasing patient population is
likely to fuel demand for these systems as it ensures efficiency and quick
response to emergencies.
The rising burden of chronic diseases has propelled the
expansion of the clinical alarm management market and is poised to demonstrate
a similar pattern in the years to come. Technological innovations by the key
players are further expected to generate more demand in the nearby future,
thus, catalyzing the growth of the global clinical alarm management market. It
is also highlighted that the rising adoption of technology in the healthcare
sector is benefitting the expansion of the clinical alarm management market
over the next couple of years. However, factors such as sleep disruption and
noise fatigue are anticipated to undermine the growth pace of the clinical
alarm management market in the foreseeable future.
Regional Analysis:
For an extensive geographical assessment of the global
clinical alarm management market, it has been segmented into four major regions
– Americas, Europe, the Middle East & Africa (MEA), and Asia Pacific.
Americas is currently holding the largest market share and is anticipated to
maintain its prominence over the next couple of years. The developed healthcare
infrastructure of the region is providing impetus to the expansion of the
clinical alarm management market. Europe is poised to maintain its position at
the second spot and is anticipated to benefit from the government support and
funds. Asia Pacific clinical alarm management market is projected to register
the highest CAGR over the assessment period.
Market Segmentation:
The different segments, on the basis of products, identified
in this study on the
clinical alarm management market insights are segmented nurse call systems,
EMR integration systems, physiological monitors, bed alarms, mobility
solutions, ventilators, central monitoring systems, and clinical
decision support tools.
The different components of the global clinical alarm
management market assessed in this MRFR report are solutions and services.
On the basis of the end-user, the clinical alarm management
market has been segmented into hospitals, ambulatory care centers & home
care settings, and long-term care centers.
Competitive Dashboard:
The market exhibits robust competition among the key players
on account of technological advancements. Since the technology is gaining
momentum among the healthcare providers, participants in the global clinical
alarm management market are anticipated to introduce innovative technologies
for staying ahead of the curve. In addition, investments are expected to be
increased in research and development for the development of product
portfolios. This, in turn, is expected to impact revenue generation of the noted
vendors favorably in the years to come.
Koninklijke Philips N.V., Vocera Communications, Medtronic,
Baxter, Mindray Medical International, Ascom Holdings, Spok, Inc. (Subsidiary
of Spok Holdings, Inc.), GE Healthcare, Masimo, Connexall, Drager, Capsule
Technologie (Subsidiary of Qualcomm Life, Inc.), Bernoulli Enterprise, Inc.,
and Mobile Heartbeat (Subsidiary of Hospital Corporation of America) are some
of the main players of the global clinical alarm management market and are
poised to earn massive revenue in the upcoming years.
The market is also projected to make way for the entry of
new players owing to the increasing number of technology startups venturing
into the healthcare sector. The most promising strategies being adopted by the
market participants for ensuring market growth are mergers & acquisitions,
partnerships, product development, collaboration, etc.
About US:
Market Research Future (MRFR), enable customers to unravel the complexity
of various industries through Cooked Research Report (CRR), Half-Cooked
Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research
(CFR), and Market Research & Consulting Services.
Market Insights
The global fetal bovine serum market is presumed to soar
high during the forecast period 2018-2023 owing to the advancements in research
and academic initiatives by the private and governmental sector. Market
Research Future Reports published their latest report on the global Fetal
Bovine Serum Market Share was valued at USD 0.9 billion in 2022 and is
projected to grow from USD 0.95 Billion in 2023 to USD 1.3 billion by 2030,
exhibiting a compound annual growth rate (CAGR) of 5.60% during the forecast
period (2023 - 2030).
Fetal bovine serum is a by-product from the beef industry
and is a crucial raw material for animal health, biotechnology, pharmaceutical
research, and diagnostic as well as other research areas.
Global Fetal Bovine Serum Market: Drivers & Trends
Increase in academic research institutes globally is driving
the demand for fetal bovine serum. There have been various governments bodies
who are collaborating with academic research institutes to support research
activities in pharmaceutical, biotechnology, diagnostics, and veterinary
industries as the fetal bovine serum is an essential element for the
development of drug and having wide applications in cell-based pharmaceutical
research.
Also, fetal bovine serum (FBS) is also considered to be the
most widely used in the growth of cell culture media owing to its high content
of embryonic procedures. These abilities of fetal bovine serum are driving to
the growth of global fetal bovine serum market. Thus, when it is used at
appropriate concentrations, it tends to supply many defined and undefined
components that satisfy specific metabolic requirements for the culture of
cells.
On the other hand, the advancement in research and academic
initiatives by researches is also expected to drive the market growth in
positive ways. There has also been observed that the surge in demand from
traditional users of serum is also encouraging the market to operate in the
years to come. Even the government bodies are investing in more extensive ways
to promote and support research activities. This, in turn, is motivating to
accelerate the growth of the global fetal bovine serum market in the years to
come.
Global Fetal Bovine Serum Market Segmentation
According to the reports published by Market Research Future
Reports has mentioned that the global fetal
bovine serum market outlook has been segmented by product type,
application, and end user.
Wherein, the fetal bovine serum market, by product type is
segmented into charcoal stripped, chromatographic, Dialyzed Fetal Bovine Serum
(FBS), exosome depleted, stem
cell, and others. Added to this, the stem cell is further segmented into
embryonic stem cells qualified, and mesenchymal stem cell qualified.
By the mode of application, the fetal bovine serum market
has been segmented into drug discovery, cell culture media, in-vitro
fertilization, human & animal vaccine production, diagnostics, and
others.
By the mode of end user, the market is segmented into
research & academic institutes, pharmaceutical, biotechnology, and others.
Regional Outlook
Region wise, the global fetal bovine serum market has
covered the main regions such as Americas, Europe, Asia-Pacific, and the Middle
East and Africa.
It has been observed that North America leads the global
fetal bovine serum market owing to the growth of the market in rapid pace
attributing to the factors such as an increase in funding events for research,
and growing awareness about the high-end fetal bovine serum among medical
professionals.
Whereas, Europe currently owes a considerable amount of
market share in the fetal bovine serum market. It is observed that, in the near
future, the region will predict with exhibiting declination in growth due to
emerging ethical issues and religious sentiments about animal-derived products.
Such a situation would result in a low market share over the forecast period.
Asia-Pacific is also projected to be the fastest growing
region for the global fetal bovine serum market owing to the infrastructural
development and increase in outsourcing of research activities to the contract
research organizations (CROs) at relatively low cost.
On the other hand, the Middle East and Africa grasp the
least share in the global fetal bovine serum market owing to the presence of
economically diverse countries, and scarcer initiatives from the government.
Key Players
Market Research Future Reports have listed the names of some
of the crucial market players of the global fetal bovine serum market. The
names are as follows, HiMedia Laboratories, Merck KGaA, Bovogen Biologicals Pty
Ltd, Atlanta Biologicals Inc., TCS Biosciences Ltd, Tissue Culture Biologicals,
Rocky Mountain Biologicals, GE Healthcare, Thermo Fisher Scientific,
Bio-Techne, PAN-Biotech, Access Biologicals, Animal Technologies Inc., Nucleus
Biologics, Biological Industries, Corning Incorporated
About US:
Market Research Future (MRFR), enable customers to unravel the complexity
of various industries through Cooked Research Report (CRR), Half-Cooked
Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research
(CFR), and Market Research & Consulting Services.
The Arterial
Blood Collection Market is projected to reach USD 1924.34 million by 2030
at 10.2% CAGR during the forecast period 2022-2030. The rise in diagnostic
procedures is shaping the demand for the arterial blood collection devices
market positively. Reports that evaluate the medical device industry have been
made accessible by Market Research Future, which creates reports on several industry
verticals that review the market development and prospects. The market is
poised to achieve a CAGR of 9.1% while amassing income worth USD 1,624.6
million by the conclusion of the forecast in 2023.
The expansion of the diagnostic sector is expected to create
momentum for the expansion of the market. Moreover, the increased detection
rate of chronic ailments is expected to encourage the progress of the arterial
blood collection devices market. The escalated investment being dedicated to
research and development in the arterial blood collection devices market is
estimated to benefit long-term growth.
Segmental Analysis
The segmental evaluation of the arterial blood collection
devices market is carried out on the basis of type, application, end user, and
region. Based on type, the market for arterial blood collection devices is
segmented into microfluidic system, lancet, needles, blood collection tubes,
vacuum blood collection system, and other devices. By application, the arterial
blood collection market is segmented into intraoperative blood salvage and
arterial blood gas sampling. The arterial blood gas sampling is further
sub-segmented into acid base status monitoring and diagnosis of disease. The
end-user based segmentation of the arterial blood collection devices market
comprises of hospitals & clinics, blood banks, laboratories, and others.
Based on the regions, the arterial blood collection devices market comprises of
Europe, the Americas, APAC, and the Middle East & Africa.
Detailed Regional Analysis
The regional assessment of the arterial blood collection
devices market includes regions such as Europe, the Americas, APAC, and the
Middle East & Africa. The Americas is responsible for a substantial market
share in 2016, as a result of growing prevalence of chronic diseases,
increasing emphasis on safe blood transfusion processes the concentration of
major market players producing blood collection devices, and widespread demand
for diagnostic services.The European region is the second principal
market and holds a significant share in the arterial blood collection devices
market. The availability of funds from the government for research and
development is anticipated to contribute to the development of the market. The
increased demand for diagnostic services in the Asia Pacific region is a
significant factor for market development. Increasing awareness about the use
of sterile blood collection devices and an escalating number of surgical
procedures are driving the market in the Asia Pacific region.The Middle
East and African region are anticipated to display steady growth in this market
owing to the growing prevalence of transmissible transfusion infections and the
demand for medical devices for diagnostics. The government has also commenced
awareness programs for safe blood transfusion procedure, which is additionally
improving the health conditions in the underdeveloped regions of Africa.
Competitive Analysis
Amplified investment in the market is likely to motivate the
positive changes in the market in the forecast period. The decrease in trade
restrictions is anticipated to create favorable opportunities for development
in the forecast period. The presence of favorable trade policies is anticipated
to improve the growth of the market in the impending period. Strong insights
into the market’s condition is motivating the expansion of the forecast period.
The offering in the market has also diversified considerably ensuring
availability of better-quality products in the market. The emergence of
specialization in production has also increasingly improved the growth
trajectory of the market. The efficiencies achieved in the allocation of
resources is expected to encourage the development of the market in the
approaching period. Moreover, increased cost efficiencies are projected to
positively impact the progress of the market in the coming years.
The chief contenders in the artificial blood collection
devices market are Terumo Medical Corporation (U.S), Bio-Rad Laboratories, Inc.
(U.S), Becton, Dickinson and Company (U.S), Qiagen (Netherlands), NIPRO Medical
Corporation (Japan), F. Hoffmann-La Roche Ltd (Switzerland), Thermo Fisher
Scientific, Inc. (U.S) and others.
About US:
Market Research Future (MRFR), enable
customers to unravel the complexity of various industries through Cooked
Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research
Reports (3R), Continuous-Feed Research (CFR), and Market Research &
Consulting Services.
Contact us:
Market Research Future (part of
Wantstats Research and Media Private Limited),
99 Hudson Street,5Th Floor, New York,
New York 10013,
United States of America
The
importance of beauty and personal appearance currently is at an all-time high
as compared to earlier times due to the development of social media
proliferation, thus boosting the Asia Pacific Aesthetics Market. Reportscreated by MRFR detail the developments in the industry that can be
expected in the market through the forecast period. The Asia
Pacific Aesthetics market size is projected to reach USD 4.3 Billion by
2032 at 9.9% CAGR during the forecast period 2023-2032.
The breakthroughs in non-invasive
procedures due to advancements in technology are estimated to further influence
the Asia Pacific Aesthetics Market
expansion. Moreover, the heightened level of affluence in the end-user base is
estimated to contribute to the Asia Pacific Aesthetics Market share in the
upcoming period.
Prominent Companies
ZELTIQ Aesthetics Inc. (U.S.), Galderma
S.A. (Switzerland), Alma Lasers (Israel), Lumenis (Israel), PhotoMedex,
Inc. (U.S.), Cutera (U.S.), Johnson
& Johnson Services, Inc. (U.S.), Solta Medical, Inc. (Canada), Syneron
Medical Ltd. (U.S.), Mentor Worldwide LLC (U.S), Merz Pharma (Germany), Integra
Lifesciences (U.S.), Cynosure Inc. (U.S.), ALLERGAN (Ireland), Sanofi (France),
are some of the leading companies in the Asia Pacific aesthetics market.
Market Segmentation
The Asia
Pacific aesthetics market has been segmented on the basis of procedures,
products, application, and end-user.
The
various procedures in the market are surgical aesthetic procedures and
nonsurgical aesthetic procedures. The surgical aesthetic procedures are
categorized into liposuction, breast augmentation, tummy tuck, eyelid surgery,
breast lift, dermabrasion, and others. On the other hand, the nonsurgical
aesthetic procedures are split into the segments of botulinum toxin, hyaluronic acid, hair removal, photorejuvenation (IPL),
chemical peel, microdermabrasion, and others.
Product-wise,
the market caters to laser and energy-based devices, skin tightening and body
contouring devices, aesthetic implants, and others. The types of skin
tightening and body contouring devices are liposuction devices, cellulite
reduction devices, cryolipolysis technology, anti-aging device, and others. The
aesthetic implants are fragmented into dental implants, breast implants, buttock augmentation,
transdermal implants, and others.
The
various applications are facial & body contouring, facial & skin
rejuvenation, breast enhancement, scar treatment, reconstructive surgery,
tattoo removal, malignant ascites, vaginal
rejuvenation, and so on.
Depending
on end-user, the market can be segmented based on hospitals & clinics,
dermatology clinics, cosmetic centers, and others.
Detailed
Regional Analysis
The
regional scrutiny of the Asia Pacific Aesthetics Market Insights consists of North America, Europe, Africa,
and the Middle East. The North American region’s Asia Pacific Aesthetics Market
is estimated to emerge as the principal regional market in the overall Americas
region. The aesthetic industry growth in the North American region is the
outcome of the speedy development in beauty treatments and various anti-aging
cosmetic operations. The Mexican aesthetic devices market in the region has
been bolstered by the mounting interest in cosmetic techniques, improving
healthcare infrastructure, intensifying problem of skin illnesses, and the
increasing number of accomplished board-certified cosmetic doctors. The
regional market of Europe is promoted to be the next highest gainer in the
worldwide market in the future, supported by the collective support given by
the government and the great population of elderly patients who need
improvement in physical form. The substantial healthcare expenditure is another
development-inducing influence in the regional market. The APAC regional market
is estimated to be driven due to the exploding patient population, swift
innovations in technology, and the profusion of lucrative prospects for global
companies in the region. The UAE aesthetic devices market in the Middle Eastern
region is mounting at an encouraging rate, because of the rising surgeries
counting facial fat grafting, breast enlargement, liposuction, and more. The
need for innovative devices and tools to ensure safer and more effective
procedures are projected to guide the Asia Pacific Aesthetics Market in the
region.
Competitive
Analysis
The
funding scenario in the market is estimated to be optimistic and conducive to
the development of the stakeholders in the market. The government policies in
several regions are very conducive to the development of the market in the
upcoming period. The advancement of production technology and processes is
estimated to augment the global market. The establishment of clear long-term
objectives by market titans is estimated to set the tone for the continuing
expansion of the market. The identification of areas for sustainable
enhancement in the supply chain is estimated to further fortify the market. The
advancement of the market is spurred by the initiatives of the leaders in the
global market, who are dedicating resources to the development of the overall
market. The scale of innovation being observed in the market is another reason
that is adding to the advancement of the global market in the future. The
detrimental impact on the environment by the business practices is estimated to
be a key component in the future growth strategies of the market.
About US:
Market Research
Future (MRFR), enable customers to unravel the complexity of various industries
through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw
Research Reports (3R), Continuous-Feed Research (CFR), and Market Research
& Consulting Services.
Market Research Future (MRFR) has published
a research report about the global neurovascular
devices market size to touch over USD 4.2 Billion by 2030. MRFR also
anticipates the global market’s growth to be at a rate of 5.7% during the
review period 2022 to 2030. This report talks about the market scenario and
future prospects regarding growth. In this report, the global neurovascular
devices market has been segmented on the basis of end-user, product,
therapeutic application, and lastly region.
Problems related to the nervous system are
serious. They cannot be seen easily, and their therapies usually lie in
surgeries where patients and doctors need to decide which surgeries are more
invasive and which are less invasive. Neurovascular devices are necessary for
treating neurovascular diseases. These devices have been developed due to
demand for minimally invasive procedures. There has never been a dearth of
neurovascular patients. Therefore, the global neurovascular devices market has
huge scope for growth. Factors contributing to the growth of this market
include favorable reimbursement policies, and ongoing product development &
commercialization.
On the basis of the end-users, this market
has been segmented into ambulatory surgical units and hospitals & clinics.
Ambulatory surgical units work for ambulatory surgery centers (ASC) that are
also known as outpatient surgery centers, same-day surgery centers, or
surgicenters. Ambulatory surgical units perform surgical procedures not
requiring an overnight hospital stay. Such surgery is commonly less complicated
than those required hospitalization.
Key Players
The key players in the global neurovascular
devices market include Abbott Laboratories (USA), Blockade Medical LLC.
(France), Delaware Corporation (USA), Evasc (Canada), Gynesonics (USA),
Johnson & Johnson Services, Inc. (the USA), Medikit Co., Ltd. (Japan),
Medtronic (USA), Merit Medical Systems Inc. (USA), MicroPort Scientific
Corporation (China), Neuravi (Israel), OxfordEndovascular (UK), Penumbra, Inc.
(USA), Rapid Medical (Israel), Sensome (France), Secant Group LLC (USA),
Stryker (USA), Terumo Corporation (Japan), and W. L. Gore & Associates,
Inc. (USA).
Segmentation:
The product-based segmentation segments the
Neurovascular
Devicesmarket insights into aneurysm coiling & embolization
devices, cerebral balloon angioplasty & stenting systems, neurovascular catheters, neuro thrombectomy devices,
and a support device. The aneurysm coiling & embolization devices segment
has been sub-segmented into embolic coils, flow diversion devices, and liquid
embolic. Embolic coils block blood flow into an aneurysm (weak area of an
artery). The embolic protection systems have been segmented into balloon
occlusion devices and distal filter devices. Cerebral angioplasty is a
procedure useful for opening the partially blocked carotid and vertebral
arteries in the neck. They can also do the same for blood vessels within the
brain. It has been segmented into is sub-segmented into carotid artery stents
and embolic protection systems. Stenting system indicates an improvement of
coronary luminal diameter in patients with symptomatic ischemic heart disease.
Neurothrombectomy devices are used for treating acute ischemic strokes. They
have been sub-segmented into aspiration devices, retrieval systems, and suction
devices. Based on therapeutic application, the market has been segmented into
the hemorrhagic stroke and ischemic strokes. A hemorrhagic stroke can be
defined as either a brain aneurysm burst or a weakened blood vessel leak. The
different types of ischemic strokes occur when the body is deprived of oxygen
or any other important nutrients.
The regional segmentation of the global
neurovascular devices market comprises of The Americas (North America &
South America), Europe, Asia Pacific, and Middle East & Africa (MEA)
region. The Americas dominate the global neurovascular devices market due to a
large number of patients suffering from neurovascular diseases like
arteriovenous malformations (AVMs) and brain aneurysm. Due to technological
advancement, high disposable income, and the availability of better medical
facilities, North America is the bigger market than South America. Moreover,
increasing healthcare expenditure, government aid to researches in the field of
medical sciences and the presence of the key players in North America boosts
the growth of the market in North America. Majority key players in this region
are based in the United States of America (USA).
Europe holds the second largest share in
global neurovascular devices market. Increasing prevalence of the neurovascular
diseases and the presence of a well-developed healthcare sector are the major
factors that drive the market growth in this region. Due to reasons same as The
Americas, Western Europe market is bigger than Eastern Europe. In Europe, most
of the key players in this market are based in France and the United Kingdom
(UK).
The Asia Pacific region is the fastest
growing market for the market due to continuously developing economies like
China and India, increasing demands for minimally invasive surgeries by the
growing geriatric population, and the presence of a huge patient population.
Asia Pacific region is yet to achieve the infrastructure development and
technological advancement as par the level of North America and Europe, and
there are few countries in this region that are technologically advanced. In
the Asia Pacific region, the biggest markets are Australia, China, India,
Japan, and South Korea, followed by the rest of Asia Pacific. MEA region is a
small market due to political instability in most countries due to movements
like Arab Spring. Lack of technology and less investment in healthcare due to
healthcare not being considered a priority by governments in this region are
the reasons for a small market. The biggest markets in this region are Kuwait,
Oman, Saudi Arabia, Qatar, and United Arab Emirates (UAE), followed by rest of
MEA region.
About US:
Market Research Future (MRFR), enable customers to
unravel the complexity of various industries through Cooked Research Report
(CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R),
Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Surgical
Robots Market Overview and analysis By Product Type, By Application, By
Control Mechanism, By End-User and Region—Forecast till 2030
The Global Surgical Robots Market is growing with the rapid
pace mainly due to the burgeoning Healthcare Industry. According to a
recent study report published by the Market Research Future, The surgical
robots market size was valued at USD 4.21 billion in 2021 and is projected to
grow from USD 5.05 Billion in 2022 to USD 21.41 billion by 2030, exhibiting a
compound annual growth rate (CAGR) of 5.8% during the forecast period (2022 -
2030).
Advancements in technology have empowered surgeons to
remotely operate robots and perform surgery. Surgeons can perform a surgical
procedure in emergency situations through telesurgery, with the aid of an
imaging device. There are many advantages of robotic surgery over
traditional open surgery like more accuracy, less pain, small insertions and
many more. Increasing automation in healthcare sector and increasing
demand for the minimally-invasive surgeries and more advances robotics has
led to growth of this market across the globe. Beside this increasing incident
of cancer, different neurological disorders and many more diseases has provided
fuel for the growth of the market. Additionally, advancements in technology
over the fast few years have been directed towards reducing costs of products.
This has led to increasing applications of these robots for various tasks.
While high cost of surgical robots, risks associated with
the robotic surgeries and the scepticism toward technology may hamper the
growth of the market. Adversely, the development of Surgical robots with high
artificial intelligence technology is driving the Surgical robots market.
Surgical Robots Global Market – Segments
The Surgical Robots Market can be segmented in to 4 key
dynamics for the convenience of the report and enhanced understanding;
Segmentation By Control Mechanism : Comprises Direct
Telemanipulator and Computer Control.
Segmentation By Robotic Surgery Approach : Comprises Supervisor-Controlled
Robotic Surgical System, Shared Control Robotic Surgical Systems, Telesurgery
Systems, Robotic Radiosurgery Systems.
Segmentation By Application : Comprises General Surgery, Cardiac
Surgery, Gynecologic Surgery, Colorectal Surgery, Urologic Surgery, Head
and Neck Surgery and other.
Segmentation By Regions : Comprises
Geographical regions - North America, Europe, APAC and Rest of the World.
Surgical Robots Global Market – Competitive
Analysis
Characterized by the presence of well-established players; Surgical
Robots market research report appears to be highly competitive. Well
established players incorporate acquisition, collaboration, partnership,
expansion, and product launch in order to gain competitive advantage in this
market and to maintain their market position. Vendors are focusing on improving
their market performance and are expanding by acquiring promising companies in
the fast-growing markets. Marketers employ a continuous improvement strategy
to analyze and update the software, implementing improvements
and launching new technologies to meet the changing needs of consumer.
These manufactures develop a well-established infrastructure that allows
seamless implementation of advanced technologies. They strive to develop
unravel design and adept technology Heavy investments are transpired in R&D
sector from the major players which is in turn helping the market to
grow.
In view of growth and immense revenue generation
opportunities potential that market is currently demonstrating is in turn
attracting several new players to enter the market. However, those new entrants
find it challenging to survive in the market with the introduction of new
technologies.
Surgical Robots Global Market – Regional Analysis
On regional basis, America has the largest market for
surgical robots. Availability of finance, well developed healthcare sector with
continuous increasing prevalence of number of diseases are the major driving
factor for America surgical robots market. North America is the major
contributor for the Americas surgical robots market. In 2016, North America
surgical robots market was USD 1,655.8 million. Europe has second leading
market which is followed by Asia Pacific region. Increasing prevalence of diseases
like cancer and many neurological disorder in Europe has help to grow this
market. Asia Pacific region is showing slow growth for surgical robot market.
Asia Pacific surgical robots market is expected to grow at a CAGR of 23.36 %
forecast period from 2017-2023
About US:
Market Research Future (MRFR), enable customers to unravel the complexity
of various industries through Cooked Research Report (CRR), Half-Cooked
Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research
(CFR), and Market Research & Consulting Services.
Malaria is a life-threatening disease that is transmitted
through the bite of infected anopheles mosquitos. The infected mosquitos
transmit the plasmodium parasite into the bloodstream of human body upon being
bitten. As the parasite enters the human body, it travels around the body to
affect the liver and matures with time. Upon attaining maturity, the parasite
enters the bloodstream to infect the red blood cells in the body. This causes
individuals suffering from malaria to frequently experience headache, vomiting,
fever, and weakness.
The Africa
malaria diagnosis & treatment market Research report is projected to
reach USD 2,467.6 Million by 2030 at 6.9% CAGR during the forecast period
2022-2030.It is reported in a study released by Market Research Future (MRFR),
that the market is positively influenced by a number of factors. A major factor
influencing this growth is the increasing advancements in technology related to
diagnostic tools and the proliferating demand for such treatments in
malaria-endemic countries. Other factors driving the market growth are rising
support from the government in terms of investment funds and an increase in the
collaboration between the research centers and the industry. Malaria diagnostic
tests play a significant role in identifying malarial cases, which thereby
boosts the growth of the overall malaria diagnostic market.
However, the lack of precise monitoring standards at
developing nations, acts as a major factor constraining the market. The lack of
awareness among emerging nations and work regulatory framework is of particular
concern for both manufacturers and healthcare providers.
Market Segmentation
The global malaria diagnostics market segmentation is done
as per technology and end-user.
By technology, the market is divided into microscopy,
molecular diagnostic tests, and rapid diagnostic tests. Furthermore, the
molecular diagnostic test is narrowed down into real-time polymerase chain
reaction (RT-PCR) and polymerase chain reaction (PCR).
By end-users, the market comprises of clinics, hospitals,
community healthcare, and others.
Regional Analysis
Geographically, the global malaria diagnostic market covers
regions such as North America, European, Asia Pacific, and Middle East &
Africa.
The North American region holds the largest share of the
malaria diagnostic market and leads the global standings. The region is further
expected to garner the largest market share during the forecast period 2018 and
2023. The market is slated for growth due to the rise in awareness, advancing
medical technologies, favorable compensation setting for various surgical
methods and procedures, medical tourism, and expanding growth of the healthcare
sector.
Competitive Landscape
The global malaria
diagnostics market Trends comprises of a number of key and prominent
players, including Leica Microsystems GmbH, Premier Medical Corporation Pvt.
Ltd, Access Bio. Inc., Beckman Coulter Inc., bioMérieux, Nikon Corporation,
Abbott Laboratories, Olympus Corporation, Sysmex Partec GmbH, Siemens
Healthineers, and Bio-Rad Laboratories Inc.
March 28th, 2019, Global Health Innovative
Technology Fund announced a total of 2.86 Billion Yen to aid 10 partnerships to
research and develop new lifesaving drugs, diagnosis, and vaccines for
disorders like Vaccines for Leishmaniasis and Malaria, Schistosomiasis,
Malaria, Tuberculosis, Dengue, and Diagnostics.
Jan 2nd, 2019, ERADA Technology Alliance LTD, one
of the leaders of innovative, rapid diagnostic solutions for early stage
detection of infectious diseases, announced the launch of one of the world’s
first diagnostic saliva test for malaria.
About US:
Market Research Future (MRFR), enable customers to unravel the complexity
of various industries through Cooked Research Report (CRR), Half-Cooked
Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research
(CFR), and Market Research & Consulting Services.
Ultrasound Devices Market Overview Analysis By Portability, By Display, By
Application, By Technology, By End-user Forecast till 2030. Ultrasound Devices Market Size was valued at USD 10.8 billion in
2022. The ultrasound devices market industry is projected to grow from USD 11.2
Billion in 2023 to USD 14.2 billion by 2030, exhibiting a compound annual
growth rate (CAGR) of 4.10% during the forecast period (2023 - 2030).The report
elaborates on the major drivers and restraints for the global ultrasound
devices market in detail by analyzing their impact on the market’s trajectory
over the forecast period.
The growing
demand for ultrasound devices for diagnostic purposes is likely to be the major
driver for the global ultrasound devices market over the forecast period.
Ultrasound devices work by sending out high-frequency sound waves that provide
a picture of the targeted area based on the response of various bodily tissues
to the sound waves. Since different tissues react differently to the same sound
waves, the technique has become popular in the healthcare sector. The lack of
invasion in the use of ultrasound equipment manufacturers has also become a key
plus point for the market due to the growing obsession with minimally invasive
and noninvasive medical procedures. Therapeutic applications of ultrasound
include targeting a specific patch of tissue for stimulation or removal by bombarding
it with high-frequency sound waves. This application is also likely to remain a
key factor for the global ultrasound devices market’s growth over the forecast
period.
Competitive Analysis:
Leading players
in the global ultrasound devices market include Siemens AG, GE, Hitachi Ltd.,
Shimadzu Corporation, Analogic Corporation, Mindray Medical International Ltd.,
Toshiba Corporation, Samsung Electronics Co. Ltd., and Koninklijke Philips NV.
Regional Analysis:
The Americas is
likely to be the major regional for ultrasound
devices market research report over the forecast period due to the
widespread adoption of advanced ultrasound technology in the region and the
growing demand for advanced diagnostic modalities and devices. Europe is also
likely to remain a major regional market for ultrasound devices over the
forecast period due to the growing healthcare expenditure in the region. Asia
Pacific is expected to exhibit the fastest growth over the forecast period due
to the growing demand for advanced medical facilities and devices and the
increasing investment in hospitals and medical technology.
Segmentation
Analysis:
By display, color devices accounted for a
largest market share in 2017 compared to its counterpart, black/white
ultrasound devices. The former can touch a size of USD 7,509.12 million by
2026, while the latter is likely to show prominent growth by the end of the
forecast period.
By application, radiology/general imaging is
likely to register highest CAGR during the assessment and likely to dominate
the market by 2026. It accounted for the largest market share in 2017 due to
its vast medical applications. The rising geriatric populace and incidence of
various cancers can spur the segment growth. On the other hand, cardiology is also showing significant growth by 2026.
By technology, diagnostic accounted for the
largest market share in 2017 due to the use of 2D ultrasound in women’s health.
It is likely to show CAGR over the assessment period and hold significant
market share by 2026 due to the continuous advances in imaging and
reimbursement schemes for these procedures. On the flip side, therapeutic
ultrasound is expected to hold second position by 2026.
About US:
Market Research
Future (MRFR), enable customers to unravel the complexity of various industries
through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw
Research Reports (3R), Continuous-Feed Research (CFR), and Market Research &
Consulting Services.